Want to join the conversation?
Biopharmaceutical company $AMGN said the US FDA has issued a Complete Response Letter for the NDA for Parsabiv for treating secondary hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis. Company is reviewing the letter, and anticipates a post-action meeting with the FDA later this year to discuss the response.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?
After so much controversy and family issues in $VIAB over the recent months, Paramount brings in some good news. News is that they signed a $1 billion deal with Shanghai Film Group and Huahua Media. The material impact to Viacom however is still uncertain.